172 related articles for article (PubMed ID: 37351109)
1. Machine learning immune-related gene based on KLRB1 model for predicting the prognosis and immune cell infiltration of breast cancer.
Huang G; Xiao S; Jiang Z; Zhou X; Chen L; Long L; Zhang S; Xu K; Chen J; Jiang B
Front Endocrinol (Lausanne); 2023; 14():1185799. PubMed ID: 37351109
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
PeerJ; 2023; 11():e15654. PubMed ID: 37520246
[TBL] [Abstract][Full Text] [Related]
4. Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
Tan W; Liu M; Wang L; Guo Y; Wei C; Zhang S; Luo C; Liu N
BMC Cancer; 2021 Feb; 21(1):126. PubMed ID: 33549054
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive analysis of the KLRB1 expression and its clinical implication in testicular germ cell tumors: A review.
Li L; Hu Y; Li X; Ju B
Medicine (Baltimore); 2024 Apr; 103(15):e37688. PubMed ID: 38608099
[TBL] [Abstract][Full Text] [Related]
6.
Liang C; Chen Y; Chen S; She J; Shi Q; Wang P
Transl Cancer Res; 2023 Dec; 12(12):3641-3652. PubMed ID: 38192989
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
Tang W; Xu F; Zhao M; Zhang S
BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
[TBL] [Abstract][Full Text] [Related]
8. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
9. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
10. Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Cheng X; Cao Y; Wang X; Cheng L; Liu Y; Lei J; Peng W; Shi D
J Immunol Res; 2022; 2022():5254911. PubMed ID: 35028320
[TBL] [Abstract][Full Text] [Related]
11. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis to screen key prognostic genes in the breast cancer tumor microenvironment.
Ye Q; Han X; Wu Z
Bioengineered; 2020 Dec; 11(1):1280-1300. PubMed ID: 33164640
[TBL] [Abstract][Full Text] [Related]
13. Low expression of
Liu X; Cui Q; Qin N
Transl Cancer Res; 2024 Mar; 13(3):1225-1240. PubMed ID: 38617516
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of pyroptotic gene prognostic signatures associated with tumor immune microenvironment and genomic mutation in breast cancer.
Zhang H; Yu X; Yang J; He G; Zhang X; Wu X; Shen L; Zhou Y; Cheng X; Liu X; Zhu Y
Front Immunol; 2022; 13():933779. PubMed ID: 36090993
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
[TBL] [Abstract][Full Text] [Related]
16. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
[TBL] [Abstract][Full Text] [Related]
17. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
Liu Y; He X; Yang YI
J Biosci; 2024; 49():. PubMed ID: 38287674
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics.
Li W; Guo X; Chen C; Li J
Lipids Health Dis; 2022 Oct; 21(1):103. PubMed ID: 36243728
[TBL] [Abstract][Full Text] [Related]
19. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma.
Pan L; Fang J; Chen MY; Zhai ST; Zhang B; Jiang ZY; Juengpanich S; Wang YF; Cai XJ
World J Gastroenterol; 2020 Feb; 26(8):789-803. PubMed ID: 32148377
[TBL] [Abstract][Full Text] [Related]
20. Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer.
Huang T; Lu C; Zhang Y; Lin BY; Zhang ZJ; Zhu D; Wang L; Lu Y
Ann Med; 2023; 55(2):2250987. PubMed ID: 38375814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
